A failure analysis of invasive breast cancer: Most death's from disease occur in women not regularly screened

Cancer

Volumn 120, Issue 18, 2014, Pages 2839-2846

  Webb, Matthew L ^a   Cady, Blake ^a,b,c   Michaelson, James S ^a,c   Bush, Devon M ^a   Calvillo, Katherina Zabicki ^c,d,e   Kopans, Daniel B ^c   Smith, Barbara L ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CAMBRIDGE HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Cancer.; Mammography; Mortality; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER SCREENING; CANCER SIZE; CANCER SURVIVAL; CAUSAL ATTRIBUTION; DEMOGRAPHY; DISTANT METASTASIS; FATALITY; FEMALE; HUMAN; INVASIVE BREAST CANCER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SURVIVAL RATE; WOMEN'S HEALTH; BREAST TUMOR; CANCER STAGING; EARLY DIAGNOSIS; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; SCREENING; STATISTICS; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

BREAST CANCER; CANCER; MAMMOGRAPHY; MORTALITY; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84908031389     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28199     Document Type: Article

References (43)

1. Smith RA, Duffy SW, Gabe R, et al. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004;42:793-806.
2. Tabar L, Duffy SW, Vitak B, et al. The natural history of breast carcinoma: what have we learned from screening? Cancer. 1999;86:449-462.
3. Tabar L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658-663.
4. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000; 355: 129-134.
5. Gotzsche PC. Relation between breast cancer mortality and screening effectiveness: systematic review of the mammography trials. Dan Med Bull. 2011;58:A4246.
6. Autier P, Boniol M, Gavin A, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011;343:d4411.
7. Welch HG. Screening mammography-a long run for a short slide? N Engl J Med. 2010;363:1276-1278.
8. Nelson HD, Fu R, Griffin JC, et al. Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med. 2009;151:703-715, W-226-735.
9. Moss SM, Cuckle H, Evans A, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-2060.
10. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011;117:714-722.
11. Coldman A, Phillips N, Warren L, et al. Breast cancer mortality after screening mammography in British Columbia women. Int J Cancer. 2007;120:1076-1080.
12. Tonelli M, Gorber SC, Joffres M, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ. 2011;183:1991-2001.
13. USPSTF. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151:716-726, W-236.
14. Swedish Organized Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006;15:45-51.
15. van Schoor G, Moss SM, Otten JD, et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011; 104:910-914.
16. Spencer DB, Potter JE, Chung MA, et al. Mammographic screening and disease presentation of breast cancer patients who die of disease. Breast J. 2004;10:298-303.
17. Centers for Disease Control and Prevention. Self-reported use of mammography among women aged > or = 40 years-United States, 1989 and 1995. MMWR Morb Mortal Wkly Rep. 1997;46: 937-941.
18. Michaelson J, Satija S, Moore R, et al. The pattern of breast cancer screening utilization and its consequences. Cancer. 2002;94:37-43.
19. Kalager M, Zelen M, Langmark F, et al. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363:1203-1210.
20. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
21. Vervoort MM, Draisma G, Fracheboud J, et al. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer. 2004;91:242-247.
22. Tabar L, Vitak B, Chen HH, et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001;91:1724-1731.
23. Tabar L, Yen MF, Vitak B, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003;361:1405-1410.
24. Michaelson JS, Kopans DB, Cady B. The breast carcinoma screening interval is important. Cancer. 2000;88:1282-1284.
25. Kopans DB. The 2009 U.S. Preventive Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn. Radiology. 2010;256:15-20.
26. Savidan A, Junker C, Cerny T, et al. Premature deaths in Switzerland from 1995-2006: causes and trends. Swiss Med Wkly. 2010; 140:w13077.
27. Bush D, Smith B, Younger J, et al. The non-breast-cancer death rate among breast cancer patients. Breast Cancer Res Treat. 2011;127: 243-249.
28. Mell LK, Jeong JH, Nichols MA, et al. Predictors of competing mortality in early breast cancer. Cancer. 2010;116:5365-5373.
29. Michaelson JS, Satija S, Kopans D, et al. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate. Cancer. 2003;98:2114-2124.
30. Hunt KA, Rosen EL, Sickles EA. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24, 211 examinations. AJR Am J Roentgenol. 1999;173:285-289.
31. Michaelson JS, Halpern E, Kopans DB. Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology. 1999;212:551-560.
32. Kopans DB, Rafferty E, Georgian-Smith D, et al. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer. 2003;97:2951-2959.
33. Carles M, Vilaprinyo E, Cots F, et al. Cost-effectiveness of early detection of breast cancer in Catalonia (Spain). BMC Cancer. 2011; 11:192.
34. Sasieni PD. Outcomes of screening to prevent cancer: think of screening as insurance. BMJ. 2003;327:50.
35. Lobb R, Ayanian JZ, Allen JD, et al. Stage of breast cancer at diagnosis among low-income women with access to mammography. Cancer. 2010;116:5487-5496.
36. Coburn N, Fulton J, Pearlman DN, et al. Treatment variation by insurance status for breast cancer patients. Breast J. 2008;14:128-134.
37. Sprague BL, Trentham-Dietz A, Gangnon RE, et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer. 2011;117:1542-1551.
38. Cronin KA, Miglioretti DL, Krapcho M, et al. Bias associated with self-report of prior screening mammography. Cancer Epidemiol Bio-markers Prev. 2009;18:1699-1705.
39. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer. 2011;117:2209-2218.
40. Gilliland FD, Joste N, Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst. 2000; 92:743-749.
41. McGarvey PB, Ladwa S, Oberti M, et al. Informatics and data quality at collaborative multicenter Breast and Colon Cancer Family Registries. J Am Med Inform Assoc. 2012;19:e125-e128
42. Byers T, Mouchawar J, Marks J, et al. The American Cancer Society challenge goals. How far can cancer rates decline in the U.S. by the year 2015? Cancer. 1999;86:715-727.
43. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212-236.